Aptar (ATR) - Price-to-Projected Revenue Ratio

Official company branding of Aptar Corp (ATR)

AptarGroup, Inc. (ATR) is a global leader in drug delivery systems and dispensers for the FMCG B2B segment. The forward price-to-sales valuation on GURU.Markets reflects the consensus trend, where 1.50 represents the latest metric value. The market values AptarGroup, Inc. (ATR) for its impeccable reliability in pharmaceuticals, while its current strategic trajectory focuses on implementing recyclable pumps and zero-waste production.

ATR (Aptar) Forward P/S Multiple history from 07/04/2022 to 11/13/2026

Comprehensive metric breakdowns and analytics for Aptar Corp (ATR)

- market price and analyst price targets:
- market capitalization indicators:
Comprehensive company analysis:ATR (Aptar)
Manufactured products of Aptar Corp

AptarGroup, Inc. (ATR) transition to recycled polymers for packaging requires capital expenditures that impact the business's market value. The current value of 1.50 reflects the ratio of market capitalization to expected revenue, allowing for daily tracking of the asset's margin of safety. By analyzing the forward P/S trend, an investor can differentiate between a fundamental weakening of the company and a temporary market undervaluation amid the industry's environmental transformation.